Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MEDIGEN VACCINE BIOLOGICS CORPORATION

(6547)
  Report
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Medigen Vaccine Biologics Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021

08/12/2021 | 07:24pm EDT

Medigen Vaccine Biologics Corporation announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was TWD 933,000 compared to TWD 1.151 million a year ago. Operating loss was TWD 455.035 million compared to TWD 172.607 million a year ago. Net loss was TWD 178.767 million compared to TWD 172.783 million a year ago. Basic loss per share was TWD 0.84 compared to TWD 0.93 a year ago. For the half year, sales was TWD 4.076 million compared to TWD 1.631 million a year ago. Operating loss was TWD 738.199 million compared to TWD 299.855 million a year ago. Net loss was TWD 335.668 million compared to TWD 304.269 million a year ago. Basic loss per share was TWD 1.59 compared to TWD 1.68 a year ago.


ę S&P Capital IQ 2021
All news about MEDIGEN VACCINE BIOLOGICS CORPORATION
10/15Phase II Data Of Medigen COVID-19 Vaccine, Reviewed And Published In The Lancet Respira..
CI
09/23MEDIGEN VACCINE BIOLOGICS : to Apply for Phase Three Clinical Trial of COVID-19 Vaccine in..
MT
09/07Vaccine makers should supply shots for trials to help spur sector -CEPI
RE
09/01Helped by TSMC and Foxconn, BioNTech vaccines finally reach Taiwan
RE
09/01Helped by tech giants, BioNTech vaccines finally reach Taiwan
RE
08/30Foxconn founder asks BioNTech to reserve 30 million more vaccines for Taiwan
RE
08/25REFILE-Taiwan to get BioNTech shots early as China delays approval-source
RE
08/23DYNAVAX TECHNOLOGIES : Medigen Vaccine Biologics Launch COVID-19 Vaccine in Taiwan
MT
08/22MEDIGEN VACCINE BIOLOGICS : Taiwan leader gets local COVID-19 vaccine as rollout begins
AQ
08/16Taiwan rejects COVID vaccine candidate, president to get domestic shot
RE
More news
Financials
Sales 2020 11,5 M 0,41 M 0,41 M
Net income 2020 -674 M -24,2 M -24,2 M
Net cash 2020 1 545 M 55,5 M 55,5 M
P/E ratio 2020 -28,6x
Yield 2020 -
Capitalization 42 286 M 1 519 M 1 520 M
EV / Sales 2019 4 269x
EV / Sales 2020 1 755x
Nbr of Employees 103
Free-Float 65,3%
Chart MEDIGEN VACCINE BIOLOGICS CORPORATION
Duration : Period :
Medigen Vaccine Biologics Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDIGEN VACCINE BIOLOGICS CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Managers and Directors
Tsan Chien Chen General Manager & Director
Yu Ping Yang Head-Finance & Accounting
Shih Chung Chang Chairman
Yi Hsu Huang Chief Technology Officer & Deputy General Manager
Ming Cheng Chang Independent Director
Sector and Competitors
1st jan.Capi. (M$)
MEDIGEN VACCINE BIOLOGICS CORPORATION112.14%1 521
CSL LIMITED4.53%101 238
WUXI BIOLOGICS (CAYMAN) INC.16.73%65 479
SAMSUNG BIOLOGICS CO.,LTD.6.42%49 817
ALEXION PHARMACEUTICALS, INC.0.00%40 336
BIOGEN INC.10.24%39 826